Physician

Leroy Arnold Pacheco, MD

According to 2025 Medicare claims, Leroy Pacheco, MD (NPI: 1568438752) practices rheumatology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is ALBUQUERQUE CENTER FOR RHEUMATOLOGY PC (NPI: 1639145808; TIN: 850446639) and primary practice location at 87102-1710. Pacheco is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Pacheco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 408 traditional Medicare patients, billed 171,910 HCPCS/CPT codes, and received $1,837,989 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 5,891 prescription claims across 607 beneficiaries totaling $4,435,080 in drug costs, led by Enbrel (Etanercept). Open Payments data shows 69 records totaling $225,002. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $619,126 to $1,837,989. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,198,420 to $4,435,080. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	293	30,810	$619,126
2016	307	44,717	$766,045
2017	357	58,250	$1,067,482
2018	370	71,962	$1,083,010
2019	373	94,281	$1,260,822
2020	341	122,607	$1,532,892
2021	339	110,918	$1,382,541
2022	336	110,123	$1,307,893
2023	312	119,936	$1,253,369
2024	408	171,910	$1,837,989

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	487	6,040	$1,198,420
2016	467	5,999	$1,438,199
2017	490	5,678	$1,577,032
2018	508	5,586	$1,669,452
2019	524	5,548	$1,856,933
2020	551	5,540	$2,390,914
2021	520	5,286	$2,522,966
2022	519	5,383	$3,096,590
2023	487	5,357	$3,986,233
2024	607	5,891	$4,435,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	75	308	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	111	128	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	293	574	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	71	281	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	91	102	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel	Etanercept	72	2,408	$668,416
Enbrel Sureclick	Etanercept	74	2,380	$639,336
Humira(Cf) Pen	Adalimumab	67	1,886	$578,774
Orencia Clickject	Abatacept	69	2,156	$448,695
Humira Pen	Adalimumab	49	1,708	$413,549

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,002	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	20	$224,000	UCB SA
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Leroy Arnold Pacheco, MD?

Tedicare shows public-source Medicare data for Leroy Arnold Pacheco, MD (NPI 1568438752), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Leroy Arnold Pacheco, MD have ACO affiliation data?

Leroy Arnold Pacheco, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Leroy Arnold Pacheco, MD?

Leroy Arnold Pacheco, MD is linked to ALBUQUERQUE CENTER FOR RHEUMATOLOGY PC (billing NPI 1639145808) in the available physician profile data.

Does Leroy Arnold Pacheco, MD have Open Payments data?

Leroy Arnold Pacheco, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.